MLTX FY 2021 Earnings — MoonLake Immunotherapeutics Revenue & Financial Results | Market Cap Arena

MLTXMoonLake Immunotherapeutics

$1B

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$4,971

Operating Income

-$54M

Net Income

-$54M

EPS (Diluted)

$-1.45

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$35M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$10M

Total Liabilities

$21M

Stockholders' Equity

-$12M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$4,971	$0	—
Operating Income	-$54M	-$105,755	-50561.4%
Net Income	-$54M	-$90,838	-58954.2%